A

Ascension | St. Clair Nephrology Research

Research site

(Unclaimed)

Location

18001 East 10 Mile Road, Suite 3, Roseville, Michigan, United States of America

Site insights

Top conditions

Top treatments

Clazakizumab

Povetacicept

VX-147

Lesinurad

BI 764198

RGLS8429

RGLS4326

Cyclosporine

CXA-10

Tacrolimus

Parent organization

This site is a part of Ascension

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 12 total trials

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study.Part 1...

Enrolling

End Stage Kidney Disease

Drug: Placebo

Drug: CSL300

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) (OLYMPUS)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of povetacicept in participants with primary membranous nephropathy (...

Enrolling

Primary Membranous Nephropathy

Drug: Tacrolimus

Drug: Povetacicept

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease (AMPLITUDE)

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling

Proteinuric Kidney Disease

Drug: VX-147

Drug: Placebo